Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

Published:2018-02-01 Issue:4 Volume:41 Page:823-830
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Hull Rebecca L.^ORCID,Gibson Ronald L.,McNamara Sharon,Deutsch Gail H.,Fligner Corinne L.,Frevert Charles W.,Ramsey Bonnie W.,Sanda Srinath

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

Cystic Fibrosis Foundation

Publisher

American Diabetes Association

Subject

Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

2. Oral glucose tolerance testing in children with cystic fibrosis

3. New insights into cystic fibrosis-related diabetes in children;Ode;Lancet Diabetes Endocrinol,2013

4. Abnormal glucose tolerance in infants and young children with cystic fibrosis;Yi;Am J Respir Crit Care Med,2016

5. Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis;Respiratory Medicine;2024-07

2. Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD;Journal of Cystic Fibrosis;2024-06

3. Current Perspectives and Innovative Approaches in Treating Cystic Fibrosis-Related Diabetes: Unveiling Mechanisms for Precision Medicine;Current Drug Therapy;2024-05-24

4. Comparison of the forms of carbohydrate metabolism in children with cystic fibrosis: A review;Consilium Medicum;2024-05-20

5. Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3